• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

BU: Smoking, alcohol consumption increase lifetime risk of atrial fibrillation

Bioengineer by Bioengineer
April 30, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Lifetime risk is a useful method to quantify risk of atrial fibrillation over a person's lifetime. However, data are scarce with respect to the lifetime risk of atrial fibrillation in the presence of one or multiple risk factors such as obesity and smoking.

Now, a new study co-authored by Boston University School of Public Health (BUSPH) researchers found that among individuals aged 55 years or older, the overall lifetime risk of atrial fibrillation (AF) was 37 percent and was influenced by the burden of risk factors.

The study was published in The BMJ.

"We examined the lifetime risk of atrial fibrillation, which measures the cumulative risk of developing a disease during the remainder of an individual's life," says co-author Ludovic Trinquart, assistant professor of biostatistics at BUSPH. "It is essential to look at lifetime risks in addition to short-term risks, because it may enable early identification of individuals at higher long-term risk and facilitate lifestyle change counseling."

The number of individuals with atrial fibrillation has been projected to rise to about 12 million to 15 million by 2050 in the United States. This increase is linked to the global increase in life expectancy. Established risk factors for developing atrial fibrillation within 10 years include cigarette smoking, alcohol misuse, hypertension, obesity, diabetes, myocardial infarction, and heart failure. However, prior research has provided little insight on the lifetime risk of atrial fibrillation.

"By contrast with the relative risk of atrial fibrillation, lifetime risk is an easy way for clinicians to communicate future risk of atrial fibrillation to individuals," the authors wrote. "Estimating the lifetime risk of atrial fibrillation in various subgroups with one or multiple elevated or borderline-elevated risk factors might also help to design preventive strategies."

The researchers assessed 5,338 participants from the Framingham Heart Study who did not have atrial fibrillation at one or more of the index ages of 55, 65, and 75 years. They identified smoking, alcohol consumption, body mass index, blood pressure, diabetes, and history of myocardial infarction or heart failure at an index age as risk factors. Then, they categorized risk factor burdens as optimal (all risk factors were optimal), elevated (at least one risk factor elevated), and borderline, and compared the lifetime risk estimates according to those levels of risk factor burden.

Risk factors present at index age 55 years considerably influenced lifetime risk. An optimal risk factor profile was associated with a lifetime risk of atrial fibrillation of 23 percent. Lifetime risk rose to about 34 percent in individuals borderline risk profile, and to 38 percent in individuals with an elevated risk factor.

The authors emphasized that preventive efforts to reduce the disease burden should target modifiable borderline and elevated risk factors.

"Studying atrial fibrillation is important because it is emerging as a global epidemic; it also imposes considerable socioeconomic burden. Atrial fibrillation hospitalizations follow an exponential increase and have surpassed heart failure admissions," Trinquart says. "Moreover, atrial fibrillation is associated with increased risks of stroke, dementia, myocardial infarction, heart failure, and premature death. Primary prevention remains largely untapped for improving AF management."

About Boston University School of Public Health:

Boston University School of Public Health, founded in 1976, offers master's- and doctoral-level education in public health. The faculty in six departments (biostatistics; community health sciences; environmental health; epidemiology; global health; and health law, policy & management) conduct policy-changing public health research around the world, with the mission of improving the health of populations–especially the disadvantaged, underserved, and vulnerable–locally, nationally, and internationally.

###

Media Contact

Meaghan Agnew
[email protected]
617-358-3367
@BUMedicine

http://www.bmc.org

Share12Tweet7Share2ShareShareShare1

Related Posts

Children’s SARS-CoV-2 Antibodies Show Stronger FcR Binding

Children’s SARS-CoV-2 Antibodies Show Stronger FcR Binding

August 23, 2025
Link Between Type 2 Diabetes and Heart Failure

Link Between Type 2 Diabetes and Heart Failure

August 23, 2025

Exploring Type 3 APS, T1DM, and LADA Insights

August 23, 2025

Thermal Vests Alleviate Mealtime Anxiety in Anorexia Patients

August 23, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Capturing a Split-Second Glimpse of Cellular Activity in Freeze-Frame

Children’s SARS-CoV-2 Antibodies Show Stronger FcR Binding

Link Between Type 2 Diabetes and Heart Failure

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.